Correlation of sLOX-1 Levels and MR Characteristics of Culprit Plaques in Intracranial Arteries with Stroke

Kaixuan Ren1,2, Huayun Jiang1, Tiantian Li1

  • 1The Second Affiliated Hospital of Nantong University, Nantong 226000, China.

Insights

Elevated soluble lectin-like oxidised low-density lipoprotein receptor-1 (sLOX-1) levels are linked to vulnerable plaque characteristics in symptomatic intracranial artery atherosclerosis (sICAS). These findings suggest sLOX-1 can help predict stroke recurrence alongside imaging.

Area of Science:

  • Neurology
  • Cardiovascular Research
  • Biomarker Discovery

Background:

  • Symptomatic intracranial artery atherosclerosis (sICAS) is a major cause of acute ischemic stroke (AIS) with high recurrence rates.
  • High-resolution magnetic resonance vessel wall imaging (HR-MR-VWI) assesses atherosclerotic plaque features.
  • Soluble lectin-like oxidised low-density lipoprotein receptor-1 (sLOX-1) is implicated in plaque development and rupture.

Purpose of the Study:

  • To investigate the association between sLOX-1 levels, HR-MR-VWI-defined culprit plaque characteristics, and stroke recurrence in sICAS patients.
  • To determine if sLOX-1 can serve as a predictive biomarker for stroke recurrence in this population.

Main Methods:

  • 199 sICAS patients underwent HR-MR-VWI for plaque assessment.
  • sLOX-1 levels were measured using ELISA.
  • Patients were followed for 12 months post-discharge to track stroke recurrence.

Main Results:

  • Higher sLOX-1 levels and more severe plaque characteristics (thickness, stenosis, burden, T1WI hyperintensity, positive remodeling, enhancement) were observed in patients with stroke recurrence.
  • Elevated sLOX-1 (> 912.19 pg/mL) and T1WI hyperintensity were identified as independent risk factors for stroke recurrence.
  • sLOX-1 levels correlated significantly with plaque thickness, stenosis, burden, and imaging features like T1WI hyperintensity, positive remodeling, and enhancement.

Conclusions:

  • sLOX-1 levels are associated with culprit plaque vulnerability in sICAS.
  • sLOX-1 serves as a valuable supplement to HR-MR-VWI for predicting stroke recurrence in sICAS patients.